Taxane-Induced Peripheral Neurotoxicity.

作者: Roser Velasco , Jordi Bruna

DOI: 10.3390/TOXICS3020152

关键词:

摘要: Taxane-derived agents are chemotherapy drugs widely employed in cancer treatment. Among them, paclitaxel and docetaxel most commonly administered, but newer formulations being investigated. Taxane antineoplastic activity is mainly based on the ability of to promote microtubule assembly, leading mitotic arrest apoptosis cells. Peripheral neurotoxicity major non-hematological adverse effect taxane, often manifested as painful neuropathy experienced during treatment, it sometimes irreversible. Unfortunately, taxane-induced an uncertainty prior initiation The present review aims dissect current knowledge real incidence, underlying pathophysiology, clinical features predisposing factors related with development neuropathy.

参考文章(110)
Cindy Tofthagen, PhD, ARNP, AOCNP®, R. Denise McAllister, MS, ARNP, AOCNP®, Constance Visovsky, PhD, RN, ACNP-BC, Peripheral neuropathy caused by Paclitaxel and docetaxel: an evaluation and comparison of symptoms. Journal of the advanced practitioner in oncology. ,vol. 4, pp. 204- 215 ,(2013) , 10.6004/JADPRO.2013.4.4.2
Wallace Akerley, James E. Herndon, Merrill J. Egorin, Alan P. Lyss, Hedy L. Kindler, Dianne M. Savarese, Carol A. Sherman, D. Marc Rosen, Donna Hollis, Mark J. Ratain, Mark R. Green, Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B. Cancer. ,vol. 97, pp. 2480- 2486 ,(2003) , 10.1002/CNCR.11375
Alexis D. Leal, Rui Qin, Pamela J. Atherton, Paul Haluska, Robert J. Behrens, Charles H. Tiber, Patanit Watanaboonyakhet, Matthias Weiss, Paul T. Adams, Travis J. Dockter, Charles L. Loprinzi, , North Central Cancer Treatment Group/Alliance trial N08CA—the use of glutathione for prevention of paclitaxel/carboplatin‐induced peripheral neuropathy: A phase 3 randomized, double‐blind, placebo‐controlled study Cancer. ,vol. 120, pp. 1890- 1897 ,(2014) , 10.1002/CNCR.28654
Andreas S. Beutler, Amit A. Kulkarni, Rahul Kanwar, Christopher J. Klein, Terry M. Therneau, Rui Qin, Michaela S. Banck, Ganesh K. Boora, Kathryn J. Ruddy, Yanhong Wu, Regenia L. Smalley, Julie M. Cunningham, Nguyet Anh Le-Lindqwister, Peter Beyerlein, Gary P. Schroth, Anthony J. Windebank, Stephan Züchner, Charles L. Loprinzi, Sequencing of charcot-marie-tooth disease genes in a toxic polyneuropathy Annals of Neurology. ,vol. 76, pp. 727- 737 ,(2014) , 10.1002/ANA.24265
N Oggioni, G Cavaletti, G Tredici, O De Negri, P Montaguti, E Cavalletti, Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat. Neurotoxicology. ,vol. 18, pp. 137- 145 ,(1997)
National Comprehensive Cancer Network, NCCN Task Force Report: Management of Neuropathy in Cancer Journal of The National Comprehensive Cancer Network. ,vol. 7, ,(2009) , 10.6004/JNCCN.2009.0078
R W Gregg, J M Molepo, V J Monpetit, N Z Mikael, D Redmond, M Gadia, D J Stewart, Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. Journal of Clinical Oncology. ,vol. 10, pp. 795- 803 ,(1992) , 10.1200/JCO.1992.10.5.795
Roy E. Smith, Ann M. Brown, Eleftherios P. Mamounas, Stewart J. Anderson, Barry C. Lembersky, James H. Atkins, Henry R. Shibata, Luis Baez, Patricia A. DeFusco, Enrique Davila, Stuart J. Tipping, James D. Bearden, Michael P. Thirlwell, Randomized Trial of 3-Hour Versus 24-Hour Infusion of High-Dose Paclitaxel in Patients With Metastatic or Locally Advanced Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-26 Journal of Clinical Oncology. ,vol. 17, pp. 3403- 3411 ,(1999) , 10.1200/JCO.1999.17.11.3403
Stephan Mielke, Klaus Mross, Thomas A. Gerds, Anja Schmidt, Ralph W??sch, Dietmar P. Berger, Winand Lange, Dirk Behringer, Comparative neurotoxicity of weekly non-break paclitaxel infusions over 1 versus 3 h Anti-Cancer Drugs. ,vol. 14, pp. 785- 792 ,(2003) , 10.1097/00001813-200311000-00003
L. Eckhoff, A. S. Knoop, M.-B. Jensen, B. Ejlertsen, M. Ewertz, Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer Breast Cancer Research and Treatment. ,vol. 142, pp. 109- 118 ,(2013) , 10.1007/S10549-013-2728-2